Indeed in this fascinating interview, CEO Adam M Hill explains how this leading immunodiagnostics firm - is becoming increasingly embedded in the drug discovery & pre-clinical testing fabric of many of the world’s largest Biopharma groups.

Plus, video also covers:

What’s been driving the surge in new ImmunoINSIGHTS contracts? Start
Importance of Master Services Agreements. 02:25
Applicability of ONC’s technology to new cutting edge drugs. 08:30
Possible investments. 11:30
Expectations for FY’23 & beyond. 13:05
Progress at EarlyCDT Lung & strategic options. 16:05
Future newsflow. 19:50


Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here